Abstract: Elucidating the intracellular fate(s) of targeted toxins is of fundamental importance for their optimal use as anticancer drugs, since the biochemical targets of their enzymatic activity reside in the cell cytoplasm, as in the case of the plant ribosome inactivating proteins (RIP) saporin, ricin and of bacterial toxins. In this paper, we compared the cell surface binding and cytotoxic properties of the model RIP ricin to an immunotoxin constructed with a monoclonal antibody directed against the human T-cell marker CD7 covalently linked to saporin (CD7-SAP). Our results indicate that, despite the fact that internalization takes place via an apparently common entry route leading to the Golgi complex, surprisingly, the addition of an endoplasmic reticulum retrieval C-terminal signal (KDEL) to CD7-SAP does not potentiate its cytotoxicity. In addition, while ricin toxicity is clearly reduced by Brefeldin A under conditions where this fungal metabolite causes Golgi stack disruption, we paradoxically observed a potentiating effect by Brefeldin A on CD7-SAP cytotoxicity suggesting that this inhibitor interferes with retrograde route(s) other than the well established Trans-Golgi Network-ER retrograde route.
Introduction
Immunotoxins (ITx) are therapeutic agents composed of a targeting domain comprised of a monoclonal antibody or a growth-factor/ligand-binding domain linked to a toxin domain via a covalent bond or alternatively as recombinant fusion protein. The ITx targeting domain confers specificity against tumor cells expressing the target antigen(s). These therapeutic agents have previously been prepared using a variety of protein toxins [1] [2] [3] and different specific targeting domains. Several ITxs have undergone clinical trials to target various haematological malignancies in vivo. Some acute leukaemias, in particular T-ALL (T-cell Acute Lymphoblastic Leukaemia), over-express CD7 [4, 5] also present on relapsed myeloid leukaemias and leukaemic progenitor cells from T-lineage leukaemia patients [6, 7] , but generally is not expressed on normal bone marrow stem cells. CD7 is a 40-kDa glycoprotein found primarily on T, NK, and pre-T cells whose putative functions in the immune system involve T and NK cell activation and/or adhesion. CD7 has, recently been identified as the cognate SECTM1 protein [8] . CD7 therefore represents a very good candidate target molecule in T-ALL for which ITxs can be constructed and specifically directed against neoplastic T-cells. In the recent past, a number of ITxs have been produced based on plant toxins such as Soapwort seed-extracted saporin [2] . Saporin from Saponaria officinalis belongs to the N-glycosidase family of plant ribosome inactivating proteins (RIPs) [1, [9] [10] [11] [12] , that also includes the powerful ricin heterodimers from Ricinus communis seeds. The latter AB toxins or Type II toxins have a lectin-like cell-binding B domain that in the case of ricin mediates cell surface binding to exposed galactose residues on glyco-proteins/-lipids, resulting in binding to the majority of mammalian cells. Once internalized by a mammalian cell, ricin follows a Trans-Golgi to endoplasmic reticulum (ER) retrograde transport route and then mimics an unfolded polypeptide to exploit the ER-associated degradation (ERAD) pathway(s), dislocating misfolded polypeptides to the cytosol for degradation [9, 13] . In this way, the A chain that possesses N-glycosidase catalytic activity gains access to the cytosol and acts on ribosomes by removing a single adenine residue (A 4324 in rat) from a stem-loop universal structure in ribosomal 28S RNA [14, 15] . This causes an irreversible block in protein synthesis followed by apoptotic cell death of the intoxicated cells [16] [17] [18] [19] . The intracellular trafficking of type I RIPs (which may be viewed as an A toxic chain without a corresponding B subunit) remains largely elusive and ITx traffic may also be dependent on the particular targeting domain used to deliver the toxin moiety. Recently, we showedthat the intracellular transport route of saporin and of saporin-based chimaeras made with human urokinase domains bypasses the Golgi apparatus [20] [21] [22] while other experiments suggested an endosomal dislocation pathway for these toxins [20] . Furthermore, when analyzing entry of a transferrin-saporin conjugate in Glioblastoma multiforme tumour cells, we demonstrated that two different signaling /intracellular pathways could be used, one p53 dependent and the other independent from the presence of a fully active p53 [23] , suggesting the possibility of an involvement of intracellular routes different from those described for chemical conjugates. In the study described here, we have characterized the binding, internalization and cytotoxic properties of an immunotoxin comprised of an anti CD7 monoclonal antibody coupled via a disulphide bond to the plant toxin saporin or to a recombinant KDEL-extended version of the same toxin We have compared their properties to those of the model toxin ricin in a view to engineering a fully recombinant molecule with an improved intracellular delivery route(s). By the use of an anti-CD7 antibody as the targeting moiety saporin is delivered to cell surface CD7, where binding is efficiently mediated via the antibody domain followed by receptor-mediated endocytosis. A main question to clarify here was if the dominant trafficking signal leads to passage through the Golgi complex, would the saporin-based ITx follow the same ricin intracellular route?
Experimental

Materials and Methods
All the reagents used were of analytical grade.
Saporin and SAP KDEL Purification
Saporin was purified from Saponaria officinalis seeds as previously described [24] . Recombinant SAP KDEL was purified from the pellet of a 1 L of culture of induced bacteria (BL21 SAP KDEL (pET11)) resuspended in 20 mM Phosphate buffer pH 6.5 supplemented with protease inhibitors (Pepstatin 1 g/mL, Leupeptin 1 g/mL, Aprotinin 10 g/mL, PMSF 15 g/mL) and DNase 1 g/mL. The suspension was sonicated and then centrifuged at 7,000 g for 30 min at +4 °C, to eliminate cells debris. The supernatant was acidified at pH 5 with diluted acetic acid, to precipitate contaminant proteins with an acidic isoelectric point. This solution was centrifuged at 7,500 g for 60 min at +4 °C. This second supernatant was recovered, neutralized at pH 6.5 and dialyzed for 48-72 h, against 20 mM Phosphate buffer pH 6.5 and filtered through 0.22 m filters before chromatographic separation. The purified Saporin fractions were then analyzed by SDS-PAGE and HPLC chromatography on an ion exchange column (Resource S; Amersham Biosciences/GE Healthcare).
Fluorescent Labeling of Saporins and Ricin
Saporin (SAP) and SAP KDEL were labeled with tetrametylrhodamine isothiocyanate (TRITC) as previously described [25] . Briefly, the toxin was reacted with a 10-fold molar excess of TRITC at pH 7.0 in 10 mM phosphate buffer overnight at 4 °C. After the reaction the protein was purified by gel filtration to remove free TRITC and then further purified by ion exchange chromatography on Sepharose Fast Flow CM (Amersham Biosciences/GE Healthcare) and eluted with a linear NaCl gradient. Ricin was labeled with fluorescein isothiocyanate, as previously described [26] . The products of these labeling reactions are designated SAP T and RICIN F , respectively.
Conjugation of Saporins to HB2 Antibody (Anti CD7)
Saporin (SAP), Saporin TRITC labeled (SAP T ) and recombinant Saporin KDEL (SAP KDEL ) were conjugated to the -CD7 HB2 monoclonal antibodies, as previously described [27] with some modification by chemical cross-linking using the hetero-bifunctional reagent SPDP (Sulfosuccinimidyl 6-(3′-[2-pyridyldithio]-propionamido)hexanoate; PIERCE/Thermo Fisher Scientific) and the thiol introducing compound 2-Iminothiolane (Traut's reagent; PIERCE/Thermo Fisher Scientific). The conjugated products (CD7-SAP, CD7-SAP T , CD7-SAP KDEL ) were then purified by gel filtration on a G200 Sephadex column and by ion exchange chromatography on a Resource S column at pH 7.0 in 10 mM phosphate buffer, eluting with NaCl gradient.
Cell Culture and Cell Viability Experiments
The CD7+ HSB-2 cell line was established originally from the peripheral blood of a paediatric patient with T-cell acute lymphoblastic leukaemia and was obtained from the European Collection of Cell Cultures (ECACC). The identity of the HSB-2 cell line was authenticated using the Identifier Plus® DNA profiling system (Applied Biosciences, Carlsbad, CA, USA) employing 15 short tandem repeat loci and the profiles obtained compared to those held on the ECACC database. Living cultures of HSB-2 were maintained at 37 °C in a 5% CO 2 atmosphere in the logarithmic phase of growth, by passage at regular intervals, in antibiotic-free RPMI 1640 medium containing 10% FCS and supplemented with 2 mM glutamine, 2 mM sodium pyruvate.
HSB-2 cells were routinely cultured under 5% CO 2 in a humidified incubator, in RPMI-10% FCS. On the day of the experiment, cells were seeded in 96-well plates at a density of 1 × 10 4 cells/mL and used the day after.
Cell viability was monitored over a period of 24-72 h in the above-indicated medium. In some experiments, pre-treatment of cells with Brefeldin-A (SIGMA Chemical Co., MO, USA) at the desired concentrations and was obtained by diluting the drug in the culture medium starting from an ethanol stock (1 mg/mL) and incubating cells before (or as in some experiments at the same time) the exposure to the various toxins and ITxs. HSB-2 cells were incubated with increasing concentrations of ricin, CD7-SAP and CD7-SAP KDEL made up as serial dilutions in tissue culture medium starting from PBS stocks.
At the end of the incubation period, we measured cell viability adding WST-1 reagent (Roche), a mitochondrial-sensitive probe, directly to the culture medium and reading absorbance ratio 440/650 nm. The data are reported as the % residual cell viability. Results (the experiment shown is representative of different experiments) are the mean of triplicate measures +/−SD.
IC 50 values have been fitted according to the equation Y = 100% / 1 + (X/IC 50 ) s where Y is the % cell viability and X is concentration of toxin used, using the program Grafit (Erithacus software).
In short time experiments, we measured 3 H-leucine incorporation in treated or untreated HSB-2 cells. Results are reported as residual protein synthesis expressed as a percentage of the untreated control cells.
Fluorescence and Confocal Microscopy
HSB-2 cells (1 × 10 5 cells/mL) were treated with RICIN F or CD7-SAP T (300 nM concentration each) for 1 h at 4 °C in PBS. After extensive washing with cold PBS, the cells were then transferred to 37 °C and further incubated for 5-60 min depending on the experiment. Cells were then fixed with 4% Para-formaldehyde in PBS and cyto-centrifuged onto a glass microscope slide. In some experiments cells were collected by cyto-spin without fixation after the incubation at 4 °C and then transferred onto a temperature controlled (37 °C) plate of a Zeiss-Axiophot fluorescence microscope and observed for fluorescence. Confocal images were obtained with a Sarastro 2000 confocal microscope.
Results
Ricin and CD7-SAP Partially Share a Common Transport Route to the Golgi
CD7 antigen represents a well-defined target molecule that is particularly suitable for the delivery of a toxin domain to the surface of malignant T-cells. We have already shown that the CD7-SAP ITx is active against CD7+ T-cell leukaemic cells [2] . In attempts to understand the intracellular route followed by the CD7-SAP ITx, we first undertook a kinetic analysis, using fluorescent confocal or fluorescent video microscopy, to investigate the internalization of CD7-SAP T obtained by crosslinking TRITC-Saporin to the HB2 monoclonal antibody, as compared to the FITC labelled model ricin holotoxin (RICIN F ), on both fixed and living HSB-2 cells.
Results shown in Figure 1A indicate a partial co-localization of RICIN F with CD7-SAP T , most likely at the level of the Golgi complex where ricin is seen to accumulate at these time points, as previously demonstrated in several reports [26, [28] [29] [30] . This was better revealed by the yellow overlapping fluorescence in the confocal analysis after 60 min incubation. Most cells show large areas containing both CD7-SAP T and RICIN F (arrows) and some discrete spots containing only CD7-SAP T (arrowheads). To explore this aspect further, we undertook a more detailed kinetic analysis, fixing cells first incubated with CD7-SAP T at ten minute time intervals for up to a 60 min period. As shown in Figure 1B , the ITx appears to be localized at the cell surface after incubation at 4 °C (t 0 ),as expected, but when internalisation is allowed to proceed at 37 °C it progressively moves into vesicular structures (presumably endosomes) after 10 and 20 min and thereafter into more compact tubular structures (presumably Golgi stacks) after 40 and 60 min. To further characterize this pathway, the kinetics of accumulation of CD7-SAP T was followed in living HSB-2 cells after CD7-SAP T binding at 4 °C following transfer of cells to a thermostatic plate at 37 °C under the microscope. Images were taken at 5 min intervals (see, Figure 1C ), and analyzed for the intensity of fluorescence within a defined intracellular perinuclear area ( Figure 1D ). As demonstrable from the images and graphics in Figure 1C ,D (and also as online supplemental information), the time course of CD7-SAP T accumulation into what is, most likely the Golgi complex area, is quite rapid, following an initial delay of approximately 20 min, and is almost complete by 40 min.
To analyze the role of Golgi complex in the intracellular routing, we also treated HSB2 cells with BFA, a drug that causes Golgi disassembly, before or after CD7-Sap T and RICIN F exposures. Videomicroscopy of cultures of living HSB-2 cells treated simultaneously with the two toxins, revealed that pre-treatment with BFA could induce an almost complete co-localisation of these two toxins (see supplemental online information). 
Addition of KDEL to CD7-SAP does not Affect Its Retrograde Transport nor Its Cytotoxicity
To further explore the possibility that the Golgi complex might be an intracellular compartment for routing this saporin-based ITx to the cytoplasm, we prepared a conjugated ITx by coupling the CD7 HB2 monoclonal antibody to a recombinant saporin (SAP KDEL ) that has been modified by appending at its C-terminus the endoplasmic reticulum retrieval sequence KDEL which is normally recognized by KDEL-receptors cycling between the Golgi complex and the ER. SAP KDEL behavior has been previously well characterized in Vero cells [22] , but due to the chemical conjugation procedure used for the construction of the ITxs [27] we reasoned that the KDEL sequence may become a possible target of SPDP the hetero-bifunctional cross-liker used for ITX construction. Therefore, after the conjugation procedure, we first analyzed the availability of the four aminoacid sequence by testing the ITx containing SAP KDEL with a monoclonal antibody directed against the KDEL sequence. As shown in Figure 2 , the main fractions eluted at 150 mM NaCl during the ion-exchange chromatography ( Figure 2A , circled peak) contained a single protein with an apparent molecular weight of approximately 180 kDa, that would correspond to the expected MW of the CD7-SAP KDEL product ( Figure 2B , fraction/lane3) following its conjugation. The ITx was recognized by both the anti saporin and anti-KDEL antibodies ( Figure 2B ), thus confirming that the cross-linking procedure did not affect the exposure of the KDEL sequence. We therefore used CD7-SAP KDEL (fraction 3) in confocal microscopy experiments, in similar conditions as described above for CD7-SAP to visualize its passage through the Golgi complex.
Indeed, CD7-SAP KDEL well co-localized inside HSB-2 cells with NBD-ceramide, an established fluorescent marker of membranes of the Trans Golgi Network (TGN), as shown in Figure 3 and as revealed by the use of the same anti-KDEL antibody followed by an anti-mouse TRITC secondary antibody. To verify whether HSB-2 cells are affected by both ricin and CD7-Saporin-based ITx treatment, cytotoxicity assays against these human T-ALL CD7 + cells were undertaken, for comparisons. All the toxins were tested in the absence or in the presence of Brefeldin A (BFA), a fungal metabolite known to inhibit ricin cytotoxicity by disrupting Golgi stacks. It should be stressed that in these experimental conditions, we had to greatly reduce the amounts of BFA normally employed to inhibit ricin cytotoxicity (5 g/mL vs. 0.05 g/mL) due to an intrinsic sensitivity of HSB-2 cells towards BFA. Figure 4 shows the toxic effects of ricin and CD7-SAP ITxs after 24 h incubation. Ricin (open squares) was found to be extremely toxic at 24 h (IC 50 estimated: 4 × 10 M) when cells were exposed for only 24 h, while its cytotoxicity was apparently not significantly affected by the presence of Brefedin A (black triangles).
Since it is well established [31] [32] [33] that ITxs may require a long delay in time before exerting their cytotoxic activity, we then also tested their activity against HSB-2 cells after 72 h of incubation.
Under these experimental conditions, ricin at all concentrations killed the majority of the HSB-2 cells and therefore we couldn't evaluate in parallel ricin cytotoxicity at 72 h.
At 72 h the viability of ITx-treated cells is clearly affected by CD7-SAP ( Figure 5 , open circles) in a dose-dependent manner and after 72 h of incubation the estimated IC 50 value is approximately 2 × 10 M. Intriguingly, we now could also observe a substantial increase of cytotoxicity for CD7-SAP KDEL in the presence of Brefeldin A at 72 h ( Figure 5 , closed triangles), a phenomenon that could be observed before only for some ricin-A-chain based immunotoxins [34] . Importantly, as compared to free saporin under the same experimental conditions (data not shown, IC 50 estimated to be 10 −6 M), both CD7-SAP and CD7-SAP KDEL ITxs are at least 4 orders of magnitude more effective than the unconjugated toxin, as would be expected. M D7-SAP, respectively), to compensate for the differences in onset of cellular cytotoxicity by each [31] [32] [33] , and also to take into account, our previous kinetic observations for each. Figure 6 refers to a protein synthesis inhibition assay conducted after 4 hours exposure of HSB-2 cells to CD7-SAP or ricin. Ricin is markedly more cytotoxic than CD7-SAP under these experimental conditions. As previously reported, ricin cytotoxicity can be inhibited [34] by Brefeldin A (at 5 g/mL) while in the same conditions, conversely, CD7-SAP cytotoxicity is scarcely influenced by the same Brefeldin A concentration.
To further characterize intracellular compartments other than the Golgi, possibly involved in CD7-SAP-mediated toxicity, we tested whether CD7-SAP, if passing through endo-lysosomal compartments, could be sensitive to the presence of chloroquine, a known potentiating agent of ITxs (causing endosomal alkalinisation) [35] . Indeed, as shown in Figure 7 the addition of Chloroquine , did increase the potency of CD7-SAP by approximately one order of magnitude. 
Discussion
The primary goal of this work was to investigate the trafficking of saporin-based anti-CD7 ITxs in order to identify if appending a KDEL sequence to the C-terminus of saporin would improve the efficiency of cytosolic delivery to target cytosolic ribosomes [9] . Based on the kinetics of CD7-SAP internalization and its partial co-localization with ricin, we further investigated the effects of appending a KDEL sequence to the C-terminus of saporin by genetic engineering of recombinant saporin reasoning that if the ITx route passed through the Trans Golgi Network-to-ER retrogade pathway, we could predict an increase in ITx performance, due to its potential interaction with KDEL receptors, normally cycling between the Golgi and ER membranes which in the case of ricin results in translocation from the ER lumen to the cytosol via sec67 in the translocon. We have therefore also analyzed the cytotoxicity of two different immunotoxins, made by chemically cross-linking a monoclonal antibody directed against the human CD7 molecule expressed on the surface of malignant T-cells to either the native SO6 isoform of the type I ribosome inactivating protein saporin, or to an ITx constructed with recombinant saporin with a KDEL sequence appended to the C-terminus peptide extended (SAP KDEL ).
When we further analyzed the kinetics of internalization of the CD7-SAP we found that it was similar to that of the model toxin ricin but that the saporin ITx took considerably longer to intoxicate HSB-2 cells than ricin ashas also been previously demonstrated for other immunotoxins [36, 37] . This delay in the onset of toxicity has been attributed to a variety of reasons that include differences in the rate of cellular uptake, the intracellular delivery route(s) to cytoplasm or in the need for an activation step necessary for to the release of free toxin.
We have demonstrated here that CD7-SAP efficiently binds the cellular membrane of target HSB-2 cells and is internalized at a rate comparable to that of ricin. After40 min, we could visualize a massive accumulation of ITx within the perinuclear zone, and after 60 min CD7-SAP partially co-localized with ricin inside perinuclear structures that have previously been demonstrated to be the Golgi apparatus [26] . One major difference between ITx and ricin uptake is lag phase of about 20 min for ITx compared to only a few minutes in the case of ricinThis is likely because there are multiple molecular structures on the plasma membrane surface of target cells that display exposed galactose residues that therefore bind ricin B chain as opposed to the single CD7 molecular structure for the ITx. Ricin can therefore potentially utilize multiple endocytic paths to gain access to the cytoplasm [38] and can thus, can intoxicate cells within a much shorter period after internalization. The question we ask is might the intracellular fate differ between ricin and CD7-SAP, despite their passage through the Golgi?
The CD7-SAP ITx binds to only a single target molecule and its cytotoxic activity was maximal after 72 h incubation. Intoxication by CD7-SAP was also found to be sensitive to the action of chloroquine, a chemical agent that disrupts proton gradients across the endosomal membrane thereby increasing the pH within acidic vesicular compartments. Furthermore, in contrast to what is observed for ricin, the activity of CD7-SAP regardless of whether or not it is carrying the KDEL sequence, cannot be inhibited by treatment with Brefeldin-A, a fungal metabolite that disrupts the integrity of Golgi apparatus thus blocking the toxicity of ricin [39] . The BFA effect on ricin cytotoxicity has been directly connected to its retrograde transport pathway [40] and explains the potential role that KDEL receptors have in retrieving back to the ER, KDEL-ricin A chain, from where the unfolded A chain translocates to the cytosol via the Sec61 translocon [41] .
Several lines of evidence suggest to us, that saporin and saporin-conjugates would normally be not able to reach the Golgi complex and thus, do not follow the same route as ricin to reach the cytosol [20] [21] [22] 25] . In the case of the type I RIP saporin, endosomal /acidic compartments are in our view the most likely sites from where translocation of this toxin to the cytoplasm occurs. We were therefore surprised to observe for the first time in the present study a saporin ITx whose intracellular localization was at least partially overlapping with that of ricin, presumably at the level of the Golgi complex.
However, despite this novel observation, the cognate CD7-SAP bearing an appended KDEL sequence did not show any potentiation of its toxicity as compared to the parental ITx. Furthermore the cytotoxicity of CD7-SAP KDEL for target HSB-2 cells like the parental ITx was not affected by BFA.
We recently demonstrated that both an unconjugated KDEL saporin and ATF-SAP KDEL , a chimeric toxin made fusing the Amino-Terminal Fragment (ATF) of urokinase to saporin showed no increase in cytotoxicity towards Vero cells as compared to their wt versions [22] . The CD7-SAP KDEL ITx used in the present study, also behaves similarly, showing after 72 h of incubation a similar cytotoxicity to that of the parent CD7-SAP ITx on HSB-2 cells, both with IC 50 values around 2 × 10
M. Interestingly, both ITxs paradoxically show an increase in their respective toxicities towards HSB-2 cells when the incubation is undertaken for 72 h in the presence of sub-optimal Brefeldin-A concentrations. This is particularly evident for the CD7-SAP KDEL ITx. One explanation is that under sub-optimal conditions, BFA may act as a sensitizing agent for target HSB-2 cells to saporin-based immunotoxins via a mechanism that is currently unknown but which may simply relate to an accumulation of toxin in endosomal compartments thus increasing the chances of translocation of toxin from here to the cytosol. The Golgi stacks or other subcellular membrane organelles in HSB-2 cells might be affected differently by this drug, possibly suggesting that under our experimental conditions a possible rerouting to the ER would occur which would not normally take place during saporin or saporinconjugate intracellular trafficking in the absence of any drug treatment.
Activation of the small soluble GTPase Arf1 is mediated by guanine nucleotide exchange factors (GEFs) that convert Arf1 to its active, GTP-bound form. BFA at high concentrations inactivates freezes Arf1-GDPcomplexes, preventing Arf1 activation, blocking membrane trafficking from the ER and Golgi apparatus thus cause Golgi disassembly [42] . However, at lower concentrations BFA might also have pleiotropic effects on other GEfs and/or might also perturb other intracellular /recycling pathways. Nevertheless, the fact that at the low BFA concentrations employed in this study, CD7-SAP KDEL appears to be more affected by the BFA treatment suggesting that interaction with recycled KDEL-receptors could be taking place under these particular conditions.
Conclusions
In conclusion, sensitization of target HSB-2 cells to CD7-SAP by BFA very likely depends on an intracellular pathway that differs from the one described for ricin. This is despite the fact that ricin and saporin initially partially co-migrate to a perinuclear region identified as the Golgi apparatus. In fact, the much longer time lag observed for CD7-SAP intoxication of HSB-2 cells compared with the considerably shorter time for ricin would also indicate that pathway(s) with differing cytosolic escape efficiencies from the lumen of vesicular compartments are followed by each toxin. The addition of a KDEL retrieval sequence to CD7-SAP KDEL did not increase ITx cytotoxicity compared with the parental CD7-SAP ITx. This would again indicate that saporin-containing ITxs, may normally exploit other intracellular compartments (different from the ER) for their cytosolic dislocation. Further characterization of saporin interactions with intracellular membranes will be needed to shed further light on the nature of this pathway(s) which may suggest novel strategies to improve saporin-based ITx killing efficiency.
Supplementary Materials
Supplementary materials can be accessed at: http://www.mdpi.com/2073-4468/2/1/50/s1.
